Despite continuing controversy regarding the relevance of CXCL-8 in cancer biology, our study revealed that CXCL-8 is a better biomarker than the currently-used classical tumor marker CEA in the diagnosis of CRC. This evidence concerns the gene CEACAM5 and neoplasm.